Equities

Icu Girisim Sermayesi Yatirim Ortakligi AS

ICUGS.E:IST

Icu Girisim Sermayesi Yatirim Ortakligi AS

Actions
FinancialsClosed End Investments
  • Price (TRY)27.38
  • Today's Change0.36 / 1.33%
  • Shares traded1.31m
  • 1 Year change+179.96%
  • Beta0.7638
Data delayed at least 15 minutes, as of Sep 20 2024 16:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TRYIncome statement in TRYView more

Year on year Icu Girisim Sermayesi Yatirim Ortakligi AS has grown net income from a loss of 11.28m to a gain of 18.91m primarily through revenue growth (0.00 to 13.21m). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the -- growth in revenues contributed enough to still see net income improve.
Gross margin61.41%
Net profit margin41.91%
Operating margin-164.18%
Return on assets2.34%
Return on equity2.81%
Return on investment2.81%
More ▼

Cash flow in TRYView more

In 2023, cash reserves at Icu Girisim Sermayesi Yatirim Ortakligi AS fell by 22.96m. Cash Flow from Investing was negative at 299.46k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 19.90m for operations while cash used for financing totalled 2.76m.
Cash flow per share0.1414
Price/Cash flow per share273.63
Book value per share5.37
Tangible book value per share5.37
More ▼

Balance sheet in TRYView more

Icu Girisim Sermayesi Yatirim Ortakligi AS has a Debt to Total Capital ratio of 9.15%.
Current ratio3.14
Quick ratio--
Total debt/total equity0.1007
Total debt/total capital0.0915
More ▼

Growth rates in TRY

Year on year, growth in earnings per share excluding extraordinary items increased 267.70%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)79.15
EPS (TTM) vs
TTM 1 year ago
-53.19
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.